Pneumatic Retinopexy

Author(s):  
Daniel A. Brinton ◽  
Charles P. Wilkinson

Pneumatic retinopexy (PR) is an office-based, sutureless, no-incision alternative to scleral buckling or vitrectomy for the surgical repair of selected retinal detachments. Cryotherapy is applied around the retinal break(s) to form a permanent seal. A gas bubble is injected into the vitreous cavity, and the patient is positioned so that the bubble closes the retinal break(s), allowing resorption of the subretinal fluid (Figure 8–1A–F). As an alternative to cryotherapy, laser photocoagulation can be applied after the intraocular gas has caused the retina to reattach. Sulfur hexafluoride (SF6) is the gas most frequently used with pneumatic retinopexy. Perfluorocarbon gases such as perfluoropropane (C3F8) are sometimes used, and success has also been reported with sterile room air. In selecting a gas, it is important to understand the longevity and expansion characteristics of the gases. SF6 doubles in volume within the eye, reaching its maximum size at about 36 hours. It will generally disappear within about 10–14 days, depending on the amount injected. Perfluoropropane nearly quadruples in volume, reaching maximum size in about three days. The bubble will last 30–45 days in the eye. Room air does not expand, but immediately starts to reabsorb. The air bubble will be gone within just a few days (Table 8–1). The initial expansion of SF6 and C3F8 is due to the law of partial pressures and the solubility coefficients of the gases involved. A 100% SF6 bubble injected into the eye contains no nitrogen or oxygen, but these gases are dissolved in the fluid around the bubble. Due to the law of partial pressures, nitrogen and oxygen will diffuse into the gas bubble. SF6 also starts to diffuse out of the gas bubble into the surrounding fluid which contains no SF6. However, nitrogen and oxygen diffuse across the gas–fluid interface much more quickly than SF6 because of the relative insolubility of SF6. The net result is an initial influx of gas molecules into the bubble, expanding its size until partial pressures equilibrate, net influx equals net egress, and maximum expansion is reached. Then the bubble gradually reabsorbs as the SF6 is slowly dissolved in the surrounding fluid.

2021 ◽  
pp. 247412642110096
Author(s):  
Jay C. Wang ◽  
William M. Tang ◽  
Dean Eliott

Purpose: This work reports on the management of a large subretinal gas bubble after pneumatic retinopexy. Methods: A case report is discussed. Results: We report a case of subretinal gas after pneumatic retinopexy for rhegmatogenous retinal detachment that was managed with a series of head-positioning maneuvers to allow the subretinal gas to migrate into the vitreous cavity through the retinal break. Despite the subretinal bubbles being larger than the retinal break, this approach eliminated the subretinal gas and averted surgical intervention. Conclusions: Subretinal gas after pneumatic retinopexy can be successfully managed by head-positioning maneuvers in some cases, even if the subretinal gas bubble is larger than the retinal break.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Wei Wei Lee ◽  
Arun Ramachandran ◽  
Hesham Hamli; ◽  
Luis C Escaf ◽  
Aditya Bansal ◽  
...  

Author(s):  
Daniel A. Brinton ◽  
Charles P. Wilkinson

Retinal detachment does not result from a single, specific disease; rather, numerous disease processes can result in the presence of subretinal fluid. The three general categories of retinal detachments are termed rhegmatogenous, exudative, and tractional. Rhegmatogenous detachments are sometimes referred to as primary detachments, while both exudative and tractional detachments are called secondary or nonrhegmatogenous detachments. The three types of retinal detachments are not mutually exclusive. For example, detachments associated with proliferative vitreoretinopathy or proliferative diabetic retinopathy may exhibit both rhegmatogenous and tractional features. However, excluding the section on differential diagnosis in Chapter 5, the scope of this book is limited to rhegmatogenous retinal detachments. Accordingly, throughout the book, the term retinal detachment refers to the rhegmatogenous type, unless another type is specifically mentioned. Rhegmatogenous detachments (from the Greek rhegma, meaning rent, rupture, or fissure) are the most common form of retinal detachment. They are caused by a break in the retina through which fluid passes from the vitreous cavity into the subretinal space. The responsible break(s) can be identified preoperatively in more than 90% of cases, but occasionally the presence of a minute, unseen break must be assumed. Exudative detachments, also called serous detachments, are due to an associated problem that produces subretinal fluid without a retinal break. This underlying problem usually involves the choroid as a tumor or an inflammatory disorder. Tractional detachments occur when pathologic vitreoretinal adhesions or membranes mechanically pull the retina away from the pigment epithelium without a retinal break. The most common causes include proliferative diabetic retinopathy, cicatricial retinopathy of prematurity, proliferative sickle retinopathy, and penetrating trauma. Retinal breaks may subsequently develop, resulting in a combined tractional and rhegmatogenous detachment. The essential requirements for a rhegmatogenous retinal detachment include a retinal break and low-viscosity vitreous liquids capable of passing through the break into the subretinal space. Vitreous changes usually precede development of important defects in the retina. The usual pathologic sequence causing retinal detachment is vitreous liquefaction followed by a posterior vitreous detachment (PVD) that causes traction at the site of significant vitreoretinal adhesion with a subsequent retinal tear. Fluids from the vitreous cavity then pass through the tear into the subretinal space (Figure 2–1), augmented by currents within the vitreous cavity caused by rotary eye movements. Although a total PVD is usually seen, many detachments occur with partial vitreous detachment, and evidence of posterior vitreous detachment may not be seen.


1994 ◽  
Vol 76 (1) ◽  
pp. 439-444 ◽  
Author(s):  
A. Ostlund ◽  
D. Linnarsson ◽  
F. Lind ◽  
A. Sporrong

Impairments of psychomotor, perceptual, and cognitive abilities were determined in nine male subjects exposed to inhaled SF6 partial pressures of 0, 52, 104, and 156 kPa and to inhaled N2 partial pressures of 103, 575, 825, and 1,075 kPa. Also data from a previous study with inhaled N2O partial pressures of 0, 13, 26, and 39 kPa were included. With the highest gas concentrations, performances were reduced by 41–57%. Effective doses for a 20% performance impairment were 830, 97, and 21.5 kPa for N2, SF6, and N2O, respectively, yielding relative narcotic potencies of 1.0:8.5:39. The order of narcotic potencies is the same as for the lipid solubility of the three gases. In contrast, the order of increasing tendency for hydrate formation (decreasing hydrate dissociation pressure) for the three gases is N2, N2O, and SF6. Thus, mild to moderate inert gas narcosis in humans shows the same positive relationship to lipid solubility as was shown in previous animal models that utilized much deeper levels of anesthesia.


Ophthalmology ◽  
1989 ◽  
Vol 96 (12) ◽  
pp. 1691-1700 ◽  
Author(s):  
Clement K. Chan ◽  
Izak F. Wessels

2005 ◽  
Vol 40 (5) ◽  
pp. 706-713 ◽  
Author(s):  
A. A. Aganin ◽  
M. A. Il'gamov ◽  
L. A. Kosolapova ◽  
B. G. Malakhov

Sign in / Sign up

Export Citation Format

Share Document